Artelo Biosciences Stock Just Whipsawed — Here’s What Traders Are Watching Now
Artelo Biosciences shares swung sharply on Friday, closing at a 52-week low before rebounding in after-hours trading, a move that put fresh attention on the small drug developer’s cash position, recent financing filings and early-stage pain pipeline.